Delivery Order SPE2DB20D7066-SPE2DB25FC2YB
- Not listed
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of 90 tablets of the prescription drug Jardiance 10 mg. The firm-fixed-price contract has a ceiling value of $23,450.17 and an ultimate completion date of August 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and this award is not associated with a set-aside program. The delivery order is part of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Jardiance 10 mg tablets. The $1,911.89 firm fixed-price contract has a completion date of June 30, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Jardiance 10 mg tablets. The contract has a firm fixed price of $6,423.63 and a completion date of May 19, 2025. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that the company holds with DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,500.50, is a firm fixed-price delivery order for the supply of Jardiance 10 mg tablets. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the contract has an ultimate completion date of December 16, 2024. This delivery order is part of a larger...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $12,782.91 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Jardiance 10 mg tablets. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp. The IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,916.18, is for the delivery of Jardiance 10 mg tablets over the period ending on April 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $83,551.76, is for the delivery of Jardiance 25 mg tablets over a period ending on May 6, 2025. The contract is a firm fixed-price, non-set-aside arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Jardiance 10 mg tablets. The $4,971.70 firm fixed-price contract has a completion date of May 12, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Jardiance 25 mg tablets. The $14,191.49 firm fixed-price contract has a completion date of December 1, 2022. Amerisourcebergen is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical...
- This is a $13,530.68 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of Jardiance 25 mg tablets, a prescription medication, to support military treatment programs and federal healthcare providers. The contract has an ultimate completion date of July 30, 2024 and is a firm-fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC2YBDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Jardiance 10 mg tablets. The contract has a firm fixed price of $16,880.08 and a period of performance through April 9, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.9k | 4/8/25 |